Catalytic Reduction of H

Mosebudi Rambevha, Ridge Chavalala, Philani Mashazi

Abstract read

In one paragraph

Article in Biosensors, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mosebudi RambevhaInstitute for Nanotechnology Innovation, Rhodes University, P.O. Box 94, Makhanda 6140, South Africa.ORCID 0000-0002-7227-7872

Ridge ChavalalaInstitute for Nanotechnology Innovation, Rhodes University, P.O. Box 94, Makhanda 6140, South Africa.ORCID 0000-0002-1538-6087

Philani MashaziInstitute for Nanotechnology Innovation, Rhodes University, P.O. Box 94, Makhanda 6140, South Africa.ORCID 0000-0003-4815-6146

Funding

Department of Science Technology and Innovation TPP NanoplatformDST/Mintek Nanotechnology Innovation Centre DST/Mintek NICNational Research Foundation CPRRRhodes University RRgTechnology Innovation Agency TPP Nanoplatform

6 · The paper itself

Abstract

Ascorbic acid (AA) or vitamin C is an important biomolecule that plays a crucial role in biological and physiological systems. Deficiency and/or excess of AA in the body can lead to severe diseases such as scurvy and gastrointestinal complications. Therefore, it is crucial to monitor the levels of AA in the body and supplements. Polyvinylpyrrolidone nickel oxide nanoparticles (PVP-NiONPs) are prepared and evaluated for their potential as nanozymes with peroxidase-like activity. o-Phenylenediamine (OPD) was used as a chromogen in the presence of hydrogen peroxide. The oxidized OPD was produced by ROS from PVP-NiONPs and H

Indexed as

Ascorbic AcidBiosensing TechniquesHydrogen PeroxideCatalysisColorimetryLimit of DetectionNanoparticlesNickelOxidation-ReductionPovidoneAscorbic AcidHydrogen PeroxideNickelnickel monoxidePovidoneascorbic acidcolorimetric sensornanozymesnickel oxide nanoparticlespolyvinylpyrrolidone

Identifiers

PMID42187495

DOI10.3390/bios16050299

PMCPMC13204353

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.